|
US6503881B2
(en)
*
|
1996-08-21 |
2003-01-07 |
Micrologix Biotech Inc. |
Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
|
|
US6180604B1
(en)
*
|
1996-08-21 |
2001-01-30 |
Micrologix Biotech Inc. |
Compositions and methods for treating infections using analogues of indolicidin
|
|
IN186245B
(https=)
|
1997-09-19 |
2001-07-14 |
Ranbaxy Lab Ltd |
|
|
US6172185B1
(en)
*
|
1998-05-20 |
2001-01-09 |
University Of British Columbia |
Antimicrobial cationic peptide derivatives of bactenecin
|
|
US8283315B2
(en)
|
1998-08-28 |
2012-10-09 |
Lytix Biopharma As |
Inhibition of tumour growth
|
|
GB9818938D0
(en)
|
1998-08-28 |
1998-10-21 |
Alpharma As |
Bioactive peptides
|
|
US6288212B1
(en)
*
|
1998-08-28 |
2001-09-11 |
The University Of British Columbia |
Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor
|
|
WO2000026344A1
(en)
*
|
1998-10-30 |
2000-05-11 |
Interlink Biotechnologies Llc |
Peptides with enhanced stability to protease degradation
|
|
US6946261B1
(en)
|
1998-11-20 |
2005-09-20 |
Migenix Inc. |
Efficient methods for producing anti-microbial cationic peptides in host cells
|
|
CA2360865A1
(en)
*
|
1999-02-03 |
2000-08-10 |
Biogal Gyogyszergyar Rt. |
Process for the preparation of pseudomonic acid a antibiotic by microbiological method
|
|
US6399570B1
(en)
*
|
1999-02-05 |
2002-06-04 |
Agennix, Inc. |
Antimicrobial/endotoxin neutralizing polypeptide
|
|
US20030008369A1
(en)
*
|
1999-03-03 |
2003-01-09 |
Board Of Regents, The University Of Texas System |
Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases
|
|
US6835868B1
(en)
|
1999-03-17 |
2004-12-28 |
University Of Victoria Innovation And Development Corporation |
Transgenic plants expressing dermaseptin peptides providing broad spectrum resistance to pathogens
|
|
WO2000055337A1
(en)
*
|
1999-03-17 |
2000-09-21 |
University Of Victoria Innovation And Development Corporation |
Transgenic plants that are resistant to a broad spectrum of pathogens
|
|
WO2001001957A1
(en)
*
|
1999-05-27 |
2001-01-11 |
Biocompatibles Limited |
Local drug delivery
|
|
US7015309B1
(en)
|
1999-06-23 |
2006-03-21 |
The Wistar Institute Of Anatomy And Biology |
Pyrrhocoricin-derived peptides, and methods of use thereof
|
|
ATE285821T1
(de)
*
|
1999-10-08 |
2005-01-15 |
Affinium Pharm Inc |
Fab i inhibitoren
|
|
WO2001045732A2
(en)
*
|
1999-12-20 |
2001-06-28 |
Sa Majesté La Reine Du Chef Du Canada Agriculture Et Agroalimentaire Canada |
Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections
|
|
CA2398808A1
(en)
*
|
2000-01-21 |
2001-07-26 |
The Wistar Institute Of Anatomy & Biology |
Biocidal molecules, macromolecular targets and methods of production and use
|
|
US8003595B2
(en)
|
2000-03-01 |
2011-08-23 |
Cellectis |
Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
|
|
US6632616B2
(en)
*
|
2000-03-16 |
2003-10-14 |
Duke University |
Compounds that selectively bind to expanded polyglutamine repeat domains and methods of use thereof
|
|
US6777592B2
(en)
*
|
2000-04-14 |
2004-08-17 |
E.I. Du Pont Denemours And Company |
Arthropod defensins of Scolopendra canidens, Vaejovis carolinianus, and Argiope spp.
|
|
DE10030781A1
(de)
*
|
2000-06-29 |
2002-01-17 |
Hassan Jomaa |
Kombinationspräparate von 3-N-Formylhydroxylaminopropylphosphonsäurederivaten oder 3-N-Acetylhydroxylaminopropylphosphonsäurederivaten mit spezielen pharmazeutischen Wirkstoffen
|
|
DE10042853A1
(de)
*
|
2000-08-30 |
2002-04-25 |
Florian Lang |
Nachweis und Beeinflußung der Expression oder Funktion von CD95/CD95L bei Infektionen
|
|
CN1455673A
(zh)
*
|
2001-01-05 |
2003-11-12 |
凯敏工业公司 |
分离自至少部分通过其皮肤进行呼吸的生物体的细菌分离物和衍生自其中的生物活性提取物
|
|
EP1357954A1
(en)
*
|
2001-02-09 |
2003-11-05 |
Johnson & Johnson Vision Care, Inc. |
Biomedical devices with antimicrobial cationic peptide coatings
|
|
CA2444597A1
(en)
*
|
2001-04-06 |
2002-10-06 |
Affinium Pharmaceuticals, Inc. |
Fab i inhibitors
|
|
CZ200467A3
(cs)
*
|
2001-06-21 |
2004-10-13 |
Biogalágyogyszergyarárt |
Metabolicky řízený způsob fermentace pro výrobu pseudomonové kyseliny
|
|
JP2004534084A
(ja)
*
|
2001-06-22 |
2004-11-11 |
ザ ホスピタル フォー シック チルドレン |
抗菌ペプチド
|
|
US6835536B2
(en)
*
|
2001-08-21 |
2004-12-28 |
Micrologix Biotech Inc. |
Antimicrobial cationic peptides and formulations thereof
|
|
JP4511173B2
(ja)
|
2001-08-24 |
2010-07-28 |
マイジェニックス インコーポレイテッド |
抗菌性および抗炎症性ペプチド
|
|
KR100438416B1
(ko)
*
|
2001-09-19 |
2004-07-02 |
학교법인조선대학교 |
Ｃａ－ｍａ 펩타이드의 아미노산 중 하나 또는 그 이상을치환하여 ＋ 전극과 소수성 영역이 증가된 신규한펩타이드 및 그를 포함하는 약학적 조성물
|
|
CN1639575A
(zh)
*
|
2001-10-05 |
2005-07-13 |
斯特里斯公司 |
用于抗朊病毒活性的体外模型
|
|
US7507787B2
(en)
*
|
2001-12-03 |
2009-03-24 |
The University Of British Columbia |
Effectors of innate immunity
|
|
PL371263A1
(en)
|
2001-12-28 |
2005-06-13 |
Biogal Gyogyszergyar Rt |
Processes for preparing crystalline and amorphous mupirocin calcium
|
|
US20040052928A1
(en)
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
|
US20030219854A1
(en)
*
|
2002-03-21 |
2003-11-27 |
Micrologix Biotech Inc. |
Methods for producing modified anti-infective peptides
|
|
US7476693B2
(en)
*
|
2002-03-26 |
2009-01-13 |
Eastern Virginia Medical School |
Suramin and derivatives thereof as topical microbicide and contraceptive
|
|
FR2839311A1
(fr)
*
|
2002-05-06 |
2003-11-07 |
Entomed |
Peptides antibacteriens, genes codant les peptides, vecteurs, organismes transformes, leurs preparations et les compositions les contenant
|
|
US7607436B2
(en)
*
|
2002-05-06 |
2009-10-27 |
The Research Foundation Of State University Of New York |
Methods, devices and formulations for targeted endobronchial therapy
|
|
EP1360961A1
(en)
*
|
2002-05-07 |
2003-11-12 |
AM-Pharma B.V. |
Use of antimicrobial peptides for potentiating the activity of antimicrobial agents
|
|
IL150907A
(en)
*
|
2002-07-25 |
2007-07-04 |
Stephan Cherkez |
Process for the preparation of stable amorphous calcium pseudomonate
|
|
EP1581236B1
(en)
*
|
2002-10-29 |
2013-10-16 |
Insmed Incorporated |
Sustained release of antiinfectives
|
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
|
EP1575951B1
(en)
|
2002-12-06 |
2014-06-25 |
Debiopharm International SA |
Heterocyclic compounds, methods of making them and their use in therapy
|
|
AU2003296937A1
(en)
*
|
2002-12-10 |
2004-06-30 |
Biosynexus Incorporated |
Topical anti-infective formulations
|
|
DE10260537A1
(de)
*
|
2002-12-21 |
2004-07-15 |
Kerek, Franz, Dr. |
Peptide mit hohem Cysteingehalt
|
|
DE602004016831D1
(de)
*
|
2003-03-17 |
2008-11-13 |
Affinium Pharm Inc |
Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend
|
|
US6900184B2
(en)
|
2003-04-14 |
2005-05-31 |
Wyeth Holdings Corporation |
Compositions containing pipercillin and tazobactam useful for injection
|
|
WO2004098643A1
(en)
*
|
2003-04-14 |
2004-11-18 |
Wyeth Holdings Corporation |
Compositions containing piperacillin and tazobactam useful for injection
|
|
EP1468697B1
(en)
*
|
2003-04-14 |
2007-12-26 |
Wyeth Holdings Corporation |
Compositions containing piperacillin and tazobactam useful for injection
|
|
US6989370B2
(en)
*
|
2003-05-01 |
2006-01-24 |
The United States Of America As Represented By The Secretary Of Agriculture |
Bacteriocins and novel bacterial strains
|
|
SE0301431D0
(sv)
|
2003-05-19 |
2003-05-19 |
Dermagen |
Novel antimicrobial peptides
|
|
US7220422B2
(en)
*
|
2003-05-20 |
2007-05-22 |
Allergan, Inc. |
Methods and compositions for treating eye disorders
|
|
JP5137400B2
(ja)
*
|
2003-06-30 |
2013-02-06 |
テル アヴィヴ ユニヴァーシティ フューチャー テクノロジー ディヴェロップメント エル．ピー． |
アミロイド関連疾患を診断および処置するためのペプチド、それに対する抗体、ならびにその使用方法
|
|
US20060121083A1
(en)
*
|
2003-07-18 |
2006-06-08 |
Technion Research & Development Foundation Ltd. |
Anti-microbial medical implants and uses thereof
|
|
AU2003904225A0
(en)
*
|
2003-08-08 |
2003-08-21 |
Ripetech Pty Limited |
Method for reducing precure during the curing of thermosetting resins
|
|
ES2330115T3
(es)
*
|
2003-08-14 |
2009-12-04 |
Cellectis |
Composicion antibacteriana, mas particilarmente contra las bacterias gram-negativas, que comprende un peptido y un agente antibacteriano ventajosamente hidrofobo.
|
|
FR2858772A1
(fr)
*
|
2003-08-14 |
2005-02-18 |
Diatos |
Composition anti bacterienne, plus particulierement contre les bacteries gram negatif, comprenant un peptide et un agent anti-bacterien avantageusement hydrophobe
|
|
US7455840B2
(en)
*
|
2003-11-19 |
2008-11-25 |
The Scripps Research Institute |
Compositions and methods to reduce mutagenesis
|
|
US20050108047A1
(en)
*
|
2003-11-19 |
2005-05-19 |
Vvii Newco 2003, Inc. |
Business methods for commercializing antibiotics
|
|
EP1732527A2
(en)
*
|
2004-03-17 |
2006-12-20 |
Mpex Pharmaceuticals, Inc. |
Use and administration of bacterial efflux pump inhibitors
|
|
US7994225B2
(en)
*
|
2004-03-17 |
2011-08-09 |
Rempex Pharmaceuticals, Inc. |
Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
|
|
US20050282755A1
(en)
*
|
2004-03-18 |
2005-12-22 |
Ansata Therapeutics, Inc. |
Compositions having antimicrobial activity and uses thereof
|
|
CA2560984A1
(en)
*
|
2004-06-01 |
2005-12-15 |
Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag |
Process for preparation of amorphous form of a drug
|
|
EP2848614A3
(en)
|
2004-06-04 |
2015-07-29 |
Debiopharm International SA |
Acrylamide derivatives as antibiotic agents
|
|
WO2006006172A2
(en)
*
|
2004-07-15 |
2006-01-19 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
|
PL1778720T3
(pl)
*
|
2004-08-18 |
2011-03-31 |
Novabiotics Ltd |
Antybakteryjne peptydy zawierające wzór zawierający argininę i/lub lizynę
|
|
US7700308B2
(en)
*
|
2004-09-16 |
2010-04-20 |
University Of Washington |
Methods for determining susceptibility to dental caries
|
|
WO2006049580A1
(en)
*
|
2004-11-04 |
2006-05-11 |
National University Of Singapore |
Anticoagulant peptides
|
|
EP1657249A1
(en)
*
|
2004-11-10 |
2006-05-17 |
Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO |
Antibiotic drosocin derivatives
|
|
SE0402807D0
(sv)
*
|
2004-11-17 |
2004-11-17 |
Dermagen Ab |
Novel antimicrobial peptides
|
|
CN101111256B
(zh)
|
2004-12-15 |
2012-04-25 |
科罗拉多大学 |
抗菌肽及其使用方法
|
|
EP1858488B2
(en)
*
|
2005-03-14 |
2022-07-20 |
Wyeth LLC |
Tigecycline compositions and methods of preparation
|
|
CA2603179A1
(en)
*
|
2005-04-05 |
2006-10-12 |
The Scripps Research Institute |
Compositions and methods for enhancing drug sensitivity and treating drug resistant infections and diseases
|
|
US7517852B2
(en)
|
2005-07-28 |
2009-04-14 |
Biosynexus Incorporated |
Compositions and methods for treating bacteria
|
|
EP1973902A2
(en)
*
|
2005-12-05 |
2008-10-01 |
Affinium Pharmaceuticals, Inc. |
3-heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
|
|
HUE029994T2
(en)
|
2005-12-08 |
2017-04-28 |
Insmed Inc |
Lipid-based compositions of antiinfectives for treating pulmonary infections
|
|
US20090312265A1
(en)
*
|
2006-02-10 |
2009-12-17 |
Dermagen Ab |
Novel antimicrobial peptides and use thereof
|
|
JP2009526046A
(ja)
*
|
2006-02-10 |
2009-07-16 |
デルマゲン アクティエボラーグ |
新規分子
|
|
EP3354260B1
(en)
*
|
2006-04-06 |
2020-12-09 |
Insmed Incorporated |
Methods for coacervation induced liposomal encapsulation and formulations thereof
|
|
WO2007133153A1
(en)
|
2006-05-16 |
2007-11-22 |
Dermagen Ab |
Improved antimicrobial peptides
|
|
IL176303A0
(en)
*
|
2006-06-14 |
2006-10-05 |
Shmuel Shraga |
Pharmaceutical composition for the treatment of otomycosis
|
|
EP2687533B1
(en)
|
2006-07-20 |
2017-07-19 |
Debiopharm International SA |
Acrylamide derivatives as FAB I inhibitors
|
|
EP2076126A4
(en)
*
|
2006-09-12 |
2011-12-28 |
Chaperone Technologies Inc |
NEW COMBINATIONS OF DNAK INHIBITORS WITH KNOWN ANTIBACTERIAL AGENTS
|
|
US20080139518A1
(en)
*
|
2006-12-04 |
2008-06-12 |
Concert, Llc |
Topical compositions for treatment of skin conditions
|
|
WO2008098374A1
(en)
|
2007-02-16 |
2008-08-21 |
Affinium Pharmaceuticals, Inc. |
Salts, prodrugs and polymorphs of fab i inhibitors
|
|
WO2008137717A1
(en)
*
|
2007-05-04 |
2008-11-13 |
Transave, Inc. |
Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
|
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
|
US20090099062A1
(en)
*
|
2007-05-31 |
2009-04-16 |
Ethan Lee |
Pyrvinium For The Treatment of Cancer
|
|
MX2010000333A
(es)
*
|
2007-07-06 |
2010-03-30 |
Laclede Inc |
Uso de enzimas hidroliticas y oxidativas para disolver la biopelicula en pasajes de vias aereas.
|
|
DE102007036128A1
(de)
*
|
2007-07-23 |
2009-02-12 |
Universität Leipzig |
Antibiotische Peptide
|
|
EP2187907A2
(en)
*
|
2007-09-11 |
2010-05-26 |
Mondobiotech Laboratories AG |
Use of tyr-w-mif-1 and urocortin 2 as therapeutic agents
|
|
WO2009046848A1
(en)
*
|
2007-09-11 |
2009-04-16 |
Mondobiotech Laboratories Ag |
Use of the peptide thymosin beta 4 alone or in combination with cecropin a as a therapeutic agent
|
|
DE102008031283A1
(de)
*
|
2008-07-02 |
2010-01-07 |
Bayer Schering Pharma Aktiengesellschaft |
Neue Bekämpfungsmöglichkeit von durch Trichomonadida hervorgerufenen Krankheiten
|
|
DE102008031284A1
(de)
*
|
2008-07-02 |
2010-01-07 |
Bayer Schering Pharma Aktiengesellschaft |
Neue Bekämpfungsmöglichkeit der Giardiose
|
|
US20100008897A1
(en)
*
|
2008-07-09 |
2010-01-14 |
Susan Daly |
Composition for providing a benefit to a keratin-containing substrate
|
|
GB0815484D0
(en)
|
2008-08-26 |
2008-10-01 |
Univ Leuven Kath |
Antibacterial agents
|
|
US20100099614A1
(en)
*
|
2008-10-06 |
2010-04-22 |
Hodges Robert S |
Antimicrobial Peptides and Methods of Use
|
|
EP2437770A4
(en)
*
|
2009-06-05 |
2013-11-06 |
Univ Colorado Regents |
ANTIMICROBIAL PEPTIDES
|
|
PL2445515T3
(pl)
|
2009-06-26 |
2016-10-31 |
|
Środki przeciwdrobnoustrojowe
|
|
AU2010264659B2
(en)
*
|
2009-06-26 |
2016-08-04 |
Lysando Aktiengesellschaft |
Antimicrobial agents
|
|
TW201125577A
(en)
*
|
2009-12-02 |
2011-08-01 |
Novozymes As |
Use of defensins for treatment of infective endocarditis
|
|
CN103298826A
(zh)
|
2010-11-15 |
2013-09-11 |
特拉维夫大学拉莫特有限公司 |
用于治疗淀粉样纤维形成相关疾病的二肽类似物
|
|
US20130345249A1
(en)
*
|
2011-01-15 |
2013-12-26 |
The Regents Of The University Of California |
Formulations for the prevention and treatment of Wolbachia-related disease
|
|
MX369828B
(es)
|
2012-05-21 |
2019-11-22 |
Insmed Inc |
Sistemas para tratar infecciones pulmonares.
|
|
SI2861608T1
(sl)
|
2012-06-19 |
2019-08-30 |
Debiopharm International Sa |
Derivati predzdravila (E)-N-metil-N-((3-metilbenzofuran-2-IL)metil)- 3-(7-okso-5,6,7,8-tetrahidro-1 ,8-nafthiridin-3-il)akrilamid
|
|
RU2018135921A
(ru)
|
2012-11-29 |
2019-02-05 |
Инсмед Инкорпорейтед |
Стабилизированные составы ванкомицина
|
|
US9096679B2
(en)
|
2012-12-03 |
2015-08-04 |
The Board Of Regents Of The University Of Oklahoma |
Peptide compounds and methods of production and use thereof
|
|
DK2925341T3
(en)
*
|
2012-12-03 |
2018-05-07 |
Univ Oklahoma |
PEPTIME RELATIONS AND PROCEDURES FOR PREPARING AND USING THEREOF
|
|
AU2014254016B2
(en)
|
2013-04-16 |
2018-02-22 |
The Board Of Regents Of The University Of Oklahoma |
Peptide compounds and methods of production and use thereof
|
|
US20200157159A1
(en)
|
2013-04-16 |
2020-05-21 |
The Board Of Regents Of The University Of Oklahoma |
Peptide compounds and compositions thereof
|
|
CN105555290B
(zh)
|
2013-05-10 |
2021-11-09 |
莱顿大学学术医院以Lumc的名义运作 |
抗微生物肽
|
|
KR101550965B1
(ko)
*
|
2013-07-31 |
2015-09-07 |
씨제이제일제당 (주) |
초고압을 이용한 야채류 식품의 제조방법
|
|
US10751440B2
(en)
*
|
2013-10-14 |
2020-08-25 |
University Of Houston System |
Esculentin 1a derivatives and uses thereof
|
|
US10059752B2
(en)
*
|
2013-10-14 |
2018-08-28 |
University Of Houston System |
Esculentin 1a derivatives and uses thereof
|
|
ES2757563T3
(es)
*
|
2013-10-31 |
2020-04-29 |
Hutchison Biofilm Medical Solutions Ltd |
Uso de péptidos en resistencia a antibióticos
|
|
WO2015063613A2
(en)
|
2013-11-01 |
2015-05-07 |
Spherium Biomed S.L. |
Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
|
|
SMT202000516T1
(it)
|
2014-05-15 |
2020-11-10 |
Insmed Inc |
Metodi per trattamento di infezioni micobatteriche polmonati non tubercolari
|
|
US10791740B2
(en)
|
2014-06-06 |
2020-10-06 |
The Curators Of The University Of Missouri |
Enhancement of antibiotic efficacy
|
|
CN107106525B
(zh)
*
|
2014-10-24 |
2021-03-19 |
红山生物医药有限公司 |
用于抑制单链rna病毒复制的治疗
|
|
ES2740273T3
(es)
*
|
2015-02-22 |
2020-02-05 |
Omnix Medical Ltd |
Péptidos antimicrobianos
|
|
KR101773390B1
(ko)
*
|
2015-05-08 |
2017-08-31 |
동아인코팜 주식회사 |
여드름 개선용 화장료 조성물
|
|
EA201890618A1
(ru)
|
2015-09-01 |
2018-10-31 |
Ферст Вэйв Байо, Инк. |
Способы и композиции для лечения состояний, ассоциированных с аномальными воспалительными ответами
|
|
MX2018010198A
(es)
|
2016-02-25 |
2019-06-12 |
Applied Biological Laboratories Inc |
Composiciones y metodos para proteger contra patogenos e irritantes transportados por el aire.
|
|
US12447166B2
(en)
|
2016-02-25 |
2025-10-21 |
Applied Biological Laboratories, Inc. |
Compositions and methods for protecting against airborne pathogens and irritants
|
|
US12594285B2
(en)
|
2016-02-25 |
2026-04-07 |
Applied Biological Laboratories, Inc. |
Compositions and methods for protecting against airborne pathogens and irritants
|
|
BR122023021456A2
(pt)
|
2016-02-26 |
2024-02-20 |
Debiopharm International S.A. |
Uso de di-hidrogeno fosfato de {6- [(e)-3-{metil[(3-metil-1-benfofuran-2- iol)metil]amino)-3- oxopro-1-en-1-il]-2-oxo-3,4-di-hidro-1,8-naftiridin-1(2h)- il}metila para tratamento de osteomielite do pé diabético e composição farmacêutica
|
|
US11185555B2
(en)
|
2016-04-11 |
2021-11-30 |
Noah James Harrison |
Method to kill pathogenic microbes in a patient
|
|
ITUA20163612A1
(it)
*
|
2016-05-19 |
2017-11-19 |
Icf Srl |
Nuovi composti attivi contro microorganismi patogeni
|
|
US11213512B2
(en)
|
2016-06-21 |
2022-01-04 |
The Curators Of The University Of Missouri |
Bis-amino acid based compound and use thereof
|
|
CN106589135B
(zh)
*
|
2016-11-25 |
2018-08-28 |
东北农业大学 |
一种靶向抗菌肽及其制备方法和应用
|
|
WO2018140518A1
(en)
*
|
2017-01-24 |
2018-08-02 |
Flagship Pioneering, Inc. |
Compositions and related methods for controlling vector-borne diseases
|
|
US20190387748A1
(en)
*
|
2017-01-24 |
2019-12-26 |
Flagship Pioneering Innovations V, Inc. |
Compositions and related methods for agriculture
|
|
AU2018213301B2
(en)
|
2017-01-24 |
2023-08-17 |
Flagship Pioneering Innovations V, Inc. |
Methods and related compositions for manufacturing food and feed
|
|
JP2020505067A
(ja)
|
2017-01-24 |
2020-02-20 |
フラグシップ パイオニアリング イノベーションズ ブイ，インコーポレーテッド |
農業用組成物及び関連する方法
|
|
CN111148523A
(zh)
|
2017-01-24 |
2020-05-12 |
旗舰创业创新五公司 |
用于控制媒介传播的疾病的组合物和相关方法
|
|
JP7231551B2
(ja)
|
2017-02-24 |
2023-03-01 |
フラグシップ パイオニアリング イノベーションズ ブイ，インコーポレーテッド |
内部共生体を調節するための組成物及び関連方法
|
|
EP3773505B1
(en)
|
2018-03-30 |
2026-04-29 |
Insmed Incorporated |
Methods for continuous manufacture of liposomal drug products
|
|
WO2019213398A1
(en)
|
2018-05-02 |
2019-11-07 |
Insmed Incorporated |
Methods for the manufacture of liposomal drug formulations
|
|
CN108434438B
(zh)
*
|
2018-06-22 |
2020-08-25 |
安徽科技学院 |
抗菌肽在制备治疗幽门螺杆菌病的药物中的用途以及药物组合物
|
|
LT3923914T
(lt)
|
2019-02-14 |
2023-07-25 |
Debiopharm International S.A. |
Afabicino kompozicija, jos gamybos būdas
|
|
CN113939306B
(zh)
|
2019-06-14 |
2024-07-19 |
德彪药业国际股份公司 |
用于治疗涉及生物膜的细菌感染的药物及其用途
|
|
US11471433B1
(en)
|
2019-08-01 |
2022-10-18 |
Flagship Pioneering Innovations V, Inc. |
Postbiotic compositions and related methods for agriculture
|
|
US10980756B1
(en)
|
2020-03-16 |
2021-04-20 |
First Wave Bio, Inc. |
Methods of treatment
|
|
CN116744917A
(zh)
|
2020-09-04 |
2023-09-12 |
礼蓝美国公司 |
适口调配物
|
|
WO2022061096A1
(en)
*
|
2020-09-17 |
2022-03-24 |
Board Of Regents, The University Of Texas System |
Pharmaceutical compositions of niclosamide and a protein
|
|
WO2026041926A1
(en)
|
2024-08-22 |
2026-02-26 |
Itc Limited |
A synergistic combination of an antimicrobial peptide and actives for hygiene applications
|
|
WO2026041925A1
(en)
|
2024-08-22 |
2026-02-26 |
Itc Limited |
A synergistic composition of an antimicrobial peptide (amp) and natural active
|
|
WO2026042045A1
(en)
|
2024-08-22 |
2026-02-26 |
Itc Limited |
Indolicidine-containing compositions for personal care/hygiene applications
|
|
CN119350439B
(zh)
*
|
2024-08-26 |
2025-12-30 |
海南大学 |
一种具有抗白色念珠菌活性的短链抗菌肽及其应用
|